NCT03101553

Brief Summary

The present study aims to examine the feasibility of a computerized treatment for social anxiety disorder. To evaluate the efficacy of the IBM protocol the investigators have developed in reducing evaluation and social threat biases, they will conduct a two-arm randomized controlled trial. Individuals with a diagnosis of social anxiety disorder (N = 50) will be randomized to one of two conditions: 1) IBM or 2) progressive muscle relaxation. Each condition will consist of eight 25 minute treatment sessions. Participants will complete two sessions per week for four weeks and will be administered assessments at pre-treatment, one week post-treatment and at 3-month follow-up. It is hypothesized that: 1) IBM will lead to greater reductions in social anxiety symptoms than the PMR condition; 2) IBM will lead to greater reductions in depression and anxiety than the PMR condition; 3) IBM will lead to greater reductions in threat interpretations and greater increases in benign interpretations than the PMR condition; 4) The effects of condition on social anxiety symptoms will be mediated by changes in social anxiety-related interpretation bias; and 5) The effects of condition will be maintained at the 3-month follow-up assessment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 5, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

January 29, 2021

Status Verified

January 1, 2021

Enrollment Period

9 months

First QC Date

March 30, 2017

Last Update Submit

January 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Social Phobia Inventory (SPIN; Davidson, 1995)

    Measures past-week social anxiety symptom severity

    change from baseline at one-week post treatment and 3-months post-treatment

Secondary Outcomes (3)

  • Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996)

    change from baseline at one-week post treatment and 3-months post-treatment

  • Beck Anxiety Inventory (BAI; Steer & Beck, 1997)

    change from baseline at one-week post treatment and 3-months post-treatment

  • Interpretations Questionnaire-modified (IQ-modified; Buhlmann et al., 2002)

    change from baseline at one-week post treatment and 3-months post-treatment

Study Arms (2)

Interpretation Bias Modification

EXPERIMENTAL

Treatment consists of eight brief sessions consisting of two tasks. In Task 1, participants read unique scenarios ("You notice someone pointing in your direction"). A sentence meant to resolve the ambiguity will appear ("This person thinks they reco\_nize you"). After filling in the missing letter, the interpretation is reinforced by requiring the participants to correctly answer "yes" or "no" to a comprehension question ("Is this person mocking you?"). In Task 2, participants are shown a word denoting a threatening ("mocking") or benign ("cheerful") interpretation. Participants are presented with an ambiguous scenario ("You hear people at a nearby table laughing") and asked to denote whether the word and the sentence are related. Participants will receive feedback based on their response.

Behavioral: Interpretation Bias Modification

Progressive Muscle Relaxation

ACTIVE COMPARATOR

Participants will receive eight brief sessions of PMR. They will listen to a PMR script (Kassinove \& Tafrate, 2002). Participants will be asked to make sure they are sitting comfortably, close their eyes, and systematically tense and release different muscle groups.

Behavioral: Progressive Muscle Relaxation

Interventions

Eight 10-25 minute sessions of interpretation modification to reduce negative interpretation biases related to negative evaluation.

Interpretation Bias Modification

Eight 15-minute sessions of progressive muscle relaxation (PMR).

Progressive Muscle Relaxation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current diagnosis of Social Anxiety Disorder according to DSM-5 criteria
  • SPIN score greater than or equal to 30
  • Must report sufficient motivation to complete treatment (i.e., score of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation))

You may not qualify if:

  • Concurrent psychotherapy or treatment for social anxiety disorder
  • Clinically significant suicidality
  • Current Alcohol Use Disorder of "Severe" severity or higher
  • Current Non-alcohol Substance Use Disorder of "Moderate" severity or higher
  • Recent changes (less than four weeks) in psychiatric medication
  • History of psychotic symptoms
  • May not have participated in a similar computerized treatment program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University, Department of Psychology

Tallahassee, Florida, 32306, United States

Location

MeSH Terms

Conditions

Phobia, Social

Interventions

Autogenic Training

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 30, 2017

First Posted

April 5, 2017

Study Start

February 10, 2017

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

January 29, 2021

Record last verified: 2021-01

Locations